Correction: Successful rituximab treatment for severe rapidly progressive interstitial lung disease with anti-MDA5 antibody-positive juvenile dermatomyositis: a case report and literature review
Pediatr Rheumatol Online J. 2022 Sep 5;20(1):76.
doi: 10.1186/s12969-022-00736-0.
1 Division of Nephrology and Rheumatology, National Center for Child Health and Development, Tokyo, Japan.
2 Division of Pulmonology, National Center for Child Health and Development, Tokyo, Japan.
3 Division of Critical Care Medicine, National Center for Child Health and Development, Tokyo, Japan.
4 Division of Nephrology and Rheumatology, National Center for Child Health and Development, Tokyo, Japan. itoshu@yokohama-cu.ac.jp.
5 Department of Pediatrics, Yokohama City University Graduate School of Medicine, 3-9, Fukuura, Kanazawa-ku, Kanagawa, Yokohama, 236-0004, Japan. itoshu@yokohama-cu.ac.jp.